Precision Diagnostics Market Trends

Skyquest Technology's expert advisors have carried out comprehensive research on the precision diagnostics market to identify the major global and regional market trends and growth opportunities for leading players and new entrants in this market. The analysis is based on in-depth primary and secondary research to understand the major market drivers and restraints shaping the future development and growth of the industry.

Precision Diagnostics Market Dynamics


Precision Diagnostics Market Driver

Demand for Personalized Therapy to Boost Market Growth

  • Personalised therapy has become well-known in recent years that genetic testing and genome sequencing are two of the most important tools used to understand the molecular basis of disease. Many genetic disorders are screened for in European countries, as early detection of these diseases can prevent the onset of symptoms or reduce the severity of the disease.
  • The backbone of the coronavirus disease 2020 response is diagnostic testing, which supports containment efforts to reduce the outbreak. Several pharmaceutical and biotechnology companies have registered preclinical and clinical tests for novel therapies against toxic viruses. Plasma therapy and immunotherapy trials are currently in the works. During the forecast period, this trend is likely to accelerate the potential market.

Precision Diagnostics Market Restraint

Lack of Awareness and Significant Costs to Restrain the Market Growth

  • Despite the immense potential in various areas of modern healthcare, high R&D costs could hinder developments in the field of precision diagnostics restricting the market growth. 
  • One of the top priorities for healthcare providers is an accurate diagnosis. Nonetheless, the faster turnaround time for results, rising demand for test kits, and inefficiency of the tests themselves are affecting market development. Aside from these factors, a strict regulatory environment for the development of new test kits in most countries acts as a major growth restraining factor.

REQUEST FOR SAMPLE

Want to customize this report? REQUEST FREE CUSTOMIZATION

FAQs

Global Precision Diagnostics Market size was valued at USD 68.07 billion in 2023 and is poised to grow from USD 80.59 billion in 2024 to USD 311.26 billion by 2032, growing at a CAGR of 18.4% during the forecast period (2025-2032).

New product launches, partnerships and investing in research & development have been a key business strategy for market. The global precision diagnostics market is fairly concentrated, with a few big and medium-sized market participants accounting for a large portion of market revenue. 'Roche (Switzerland) ', 'GE Healthcare (United States) ', 'Abbott Laboratories (United States) ', 'Philips Healthcare (Netherlands) ', 'Danaher Corporation (United States) ', 'Quest Diagnostics (United States) ', 'Fujifilm Medical (Japan) ', 'Becton, Dickinson and Company (United States) ', 'Siemens Healthineers (Germany) ', 'Hologic Inc. (United States) ', 'QIAGEN (Germany) ', 'Grifols (Spain) ', 'Beckman Coulter (United States) ', 'bioMerieux (France) ', 'Thermo Fisher Scientific (United States) ', 'PerkinElmer (United States) ', 'Illumina (United States) ', 'Agilent Technologies (United States) ', 'Bio-Rad Laboratories (United States) ', 'Merck Group (Germany)'

Personalised therapy has become well-known in recent years that genetic testing and genome sequencing are two of the most important tools used to understand the molecular basis of disease. Many genetic disorders are screened for in European countries, as early detection of these diseases can prevent the onset of symptoms or reduce the severity of the disease.

Rise in Prevalence of Cancer: The prevalence of cancer has grown globally. Concurrently, developments in cancer diagnosis, prevention, and treatment have increased. With advancements in precision diagnostics and therapies, as well as game-changing innovations such as Next Generation Sequencing (NGS) and big genomic data, the market is expected to grow progressively over the forecast period.

The presence of a large number of leading pharmaceutical and biotech companies, as well as well-established healthcare infrastructure, North America and Europe account for the largest share of the global market. Furthermore, government support, combined with increased R&D investment, is propelling these regional markets. For instance, the then-U.S. government announced the Precision Medicine Initiative in 2015 in order to improve research and development in this field.

Request Free Customization

Want to customize this report? This report can be personalized according to your needs. Our analysts and industry experts will work directly with you to understand your requirements and provide you with customized data in a short amount of time. We offer $1000 worth of FREE customization at the time of purchase.

logo-images

Feedback From Our Clients

Precision Diagnostics Market
Precision Diagnostics Market

Report ID: SQMIG35G2102

[email protected]
USA +1 351-333-4748

BUY NOW GET FREE SAMPLE